ahlam1399
09-04-2015, 03:13 PM
Roche haemophilia drug wins fast-track FDA designation
ZURICH, Sept 4 (Reuters) - Roche said on Friday it had won breakthrough therapy designation from the U.S. Food and Drug Administration for an experimental haemophilia medicine, aiming for a piece of the $11 billion haemophilia drug market.
http://rc.feedsportal.com/r/238385206656/u/49/f/654213/c/35217/s/49907f7f/sc/21/rc/1/rc.img (http://rc.feedsportal.com/r/238385206656/u/49/f/654213/c/35217/s/49907f7f/sc/21/rc/1/rc.htm)
http://rc.feedsportal.com/r/238385206656/u/49/f/654213/c/35217/s/49907f7f/sc/21/rc/2/rc.img (http://rc.feedsportal.com/r/238385206656/u/49/f/654213/c/35217/s/49907f7f/sc/21/rc/2/rc.htm)
http://rc.feedsportal.com/r/238385206656/u/49/f/654213/c/35217/s/49907f7f/sc/21/rc/3/rc.img (http://rc.feedsportal.com/r/238385206656/u/49/f/654213/c/35217/s/49907f7f/sc/21/rc/3/rc.htm)
http://da.feedsportal.com/r/238385206656/u/49/f/654213/c/35217/s/49907f7f/sc/21/a2.img (http://da.feedsportal.com/r/238385206656/u/49/f/654213/c/35217/s/49907f7f/sc/21/a2.htm)
http://adchoice.feedsportal.com/r/238385206656/u/49/f/654213/c/35217/s/49907f7f/sc/21/ach.img (http://adchoice.feedsportal.com/r/238385206656/u/49/f/654213/c/35217/s/49907f7f/sc/21/ach.htm)http://pi.feedsportal.com/r/238385206656/u/49/f/654213/c/35217/s/49907f7f/sc/21/a2t.imghttp://pi2.feedsportal.com/r/238385206656/u/49/f/654213/c/35217/s/49907f7f/sc/21/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/49907f7f/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=HNxcfzMtnC0:h6BbO1wMh9w:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=HNxcfzMtnC0:h6BbO1wMh9w:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=HNxcfzMtnC0:h6BbO1wMh9w:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=HNxcfzMtnC0:h6BbO1wMh9w:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=HNxcfzMtnC0:h6BbO1wMh9w:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/HNxcfzMtnC0
ZURICH, Sept 4 (Reuters) - Roche said on Friday it had won breakthrough therapy designation from the U.S. Food and Drug Administration for an experimental haemophilia medicine, aiming for a piece of the $11 billion haemophilia drug market.
http://rc.feedsportal.com/r/238385206656/u/49/f/654213/c/35217/s/49907f7f/sc/21/rc/1/rc.img (http://rc.feedsportal.com/r/238385206656/u/49/f/654213/c/35217/s/49907f7f/sc/21/rc/1/rc.htm)
http://rc.feedsportal.com/r/238385206656/u/49/f/654213/c/35217/s/49907f7f/sc/21/rc/2/rc.img (http://rc.feedsportal.com/r/238385206656/u/49/f/654213/c/35217/s/49907f7f/sc/21/rc/2/rc.htm)
http://rc.feedsportal.com/r/238385206656/u/49/f/654213/c/35217/s/49907f7f/sc/21/rc/3/rc.img (http://rc.feedsportal.com/r/238385206656/u/49/f/654213/c/35217/s/49907f7f/sc/21/rc/3/rc.htm)
http://da.feedsportal.com/r/238385206656/u/49/f/654213/c/35217/s/49907f7f/sc/21/a2.img (http://da.feedsportal.com/r/238385206656/u/49/f/654213/c/35217/s/49907f7f/sc/21/a2.htm)
http://adchoice.feedsportal.com/r/238385206656/u/49/f/654213/c/35217/s/49907f7f/sc/21/ach.img (http://adchoice.feedsportal.com/r/238385206656/u/49/f/654213/c/35217/s/49907f7f/sc/21/ach.htm)http://pi.feedsportal.com/r/238385206656/u/49/f/654213/c/35217/s/49907f7f/sc/21/a2t.imghttp://pi2.feedsportal.com/r/238385206656/u/49/f/654213/c/35217/s/49907f7f/sc/21/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/49907f7f/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=HNxcfzMtnC0:h6BbO1wMh9w:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=HNxcfzMtnC0:h6BbO1wMh9w:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=HNxcfzMtnC0:h6BbO1wMh9w:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=HNxcfzMtnC0:h6BbO1wMh9w:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=HNxcfzMtnC0:h6BbO1wMh9w:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/HNxcfzMtnC0